In cervical cancer, upregulation of CXCL1/CXCL2 is associated with malignant tumor phenotypes (larger tumor size, lymph node (LYN) metastasis, and shorter patient survival) [119]. This evidence concerns the gene CXCL1 and cervical cancer.